Medical device company DexCom (NASDAQ:DXCM) reported Q4 CY2024 results , with sales up 7.6% year on year to $1.11 billion.

Looking forward, DexCom's management has reiterated its fiscal year 2025 forecast, anticipating revenue growth of 14% with a ...

Today, Benzinga's options scanner identified 8 options transactions for DexCom. This is an unusual occurrence. The sentiment ...

In March 2024, the Food and Drug Administration cleared Dexcom’s Stelo as the first over-the-counter continuous glucose monitor available ... 3% and time in range by 7%—both small amounts.

Continuous glucose monitoring (CGM) devices provide real-time blood sugar readings 24 hours a day, allowing people with type 1 or type 2 diabetes to closely track blood glucose levels and trends. Most ...

There’s not a moment in the day free from the burden of tracking ... Until then, if you need a primer on continuous glucose monitoring, we’re happy to oblige.

How To Add Dexcom Glucose Monitoring To Your Samsung Watch With G Watch App on sale, The 2 Simple apps I use to view Dexcom from my GALAXY WATCH on sale, How to view Dexcom G6 On Samsung Watch on sale ...

The FDA has cleared Dexcom’s Stelo as the first continuous glucose monitoring (CGM) device that does not need a prescription, which can be used by diabetics on oral medications, as well as non ...

Latin America continuous glucose monitoring device market is estimated to be valued at US$ 219.3 mn in 2025 and is expected to exhibit a CAGR of 15.8% by 2032 BURLINGAME, CA, UNITED STATES ...

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM ... domestic CGM market in the US to reach $7.8 billion in 2025 and more than $10 billion ...

Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ...